ACTH and renin in 529 healthy youths: associations to sex, puberty and contraceptives.
P B Edström, S A Holmboe, L Vilmann...
https://pubmed.ncbi.nlm.nih.gov/41693548Actively Recruiting
Led by Rigshospitalet, Denmark · Updated on 2024-01-10
3000
Participants Needed
1
Research Sites
1565 weeks
Total Duration
R
Rigshospitalet, Denmark
Lead Sponsor
E
Environmental Protection Agency (EPA)
Collaborating Sponsor
Researchers are studying healthy Danish school children to investigate whether the age at which puberty starts has continued to decline over the past 15 years. The study also aims to understand the causes of earlier puberty onset and examine the long-term health risks linked to extremely early puberty using national registry data. This combined cross-sectional and longitudinal study includes children aged 5 to 19 years. In the cross-sectional part, children will be examined once through clinical assessments that include height, weight, body fat, blood pressure, and puberty stage evaluations based on Tanner criteria. Blood and urine samples will be collected to measure various hormones, growth factors, endocrine disruptors, and genetic material. Additionally, children will complete electronic questionnaires about their growth, health, lifestyle, and family puberty history. The biological samples will be temporarily stored until July 2026, after which unused samples will be stored long term in a biobank. The longitudinal part of the study will use registry data to follow children diagnosed with extremely early puberty and matched controls over up to 20 years. Researchers will analyze the risk of disease and death in these groups, adjusting for factors like maternal health and birth measurements. During the study, participants will undergo clinical exams, sample collection, and complete questionnaires. The main outcomes measured are pubertal development over eight years and long-term health risks after early puberty.
CONDITIONS
The 3rd COPENHAGEN Puberty Study
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo a one-time clinical medical examination and sample collection to assess pubertal development and various biological markers.
1 visit (in-person)
Duration - Up to 20 years
Participants are followed over many years via registry-based data to assess long-term disease and death risk after extremely early puberty.
No in-person visits; data collected through national registries
Total: 1 location
1
Rigshospitalet, Department of Growth and Reproduction
Copenhagen, Denmark, 2100
Actively Recruiting
A
Anders Juul, PhD, DMSc
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
P B Edström, S A Holmboe, L Vilmann...
https://pubmed.ncbi.nlm.nih.gov/41693548